Table 2 Summary of meta-analysis results for the prevalence of occult hepatitis BÂ in Egypt
From: Prevalence of occult hepatitis B virus infection in Egypt: a systematic review with meta-analysis
Target population | No. of estimates | Participants tested for HBV DNA (n) | Pooled proportion (%) | 95% CI | Heterogeneity | ||
|---|---|---|---|---|---|---|---|
I2% (inconsistency) | Cochran Q | P value | |||||
Patients on hemodialysis | 8 | 744 | 17 | [10–25] | 94.8 | 136.7 |  < 0.01 |
Multi-transfused patients | 4 | 285 | 41 | [23–59] | 90.58 | 31.86 |  < 0.01 |
Patients with chronic HCV | 16 | 1581 | 10 | [7–13] | 79.65 | 73.71 |  < 0.01 |
Patients with HCC | 5 | 226 | 24 | [15–32] | 58.1 | 9.5 |  < 0.01 |
Patients with liver cirrhosis | 3 | 124 | 13 | [1–25] | 79.06 | 9.55 |  < 0.01 |
Occult hepatitis B virus prevalence in HBsAg-negative and anti-HBc-positive | |||||||
 Blood donors | 6 | 661 | 12 | [7–17] | 72.7 | 18.3 |  < 0.01 |
 Patients with chronic HCV | 5 | 176 | 15 | [8–22] | 45.29 | 5.48 | 0.14 |
 Patients with HCC | 3 | 157 | 31 | [1–60] | 96.82 | 62.90 |  < 0.01 |